ShotTrackr: GLP-1 & Peptide
ShotTrackr: GLP-1 & Peptide is a medical utility for tracking injectable medication doses, inventory, and reconstitution math on iOS.
The App DNA
What makes this app unique?
Users choose ShotTrackr: GLP-1 & Peptide to eliminate the recurring costs and data-privacy risks associated with cloud-connected, subscription-based health trackers.
For Individuals managing injectable medication protocols, specifically GLP-1, peptide therapy, or TRT, who prioritize data privacy and local storage.
Key features
Calculates draw units based on vial size and BAC water volume, replacing manual math.
Links backup vials to active ones for automated inventory tracking.
Imports and exports weight data for integration into broader health habits.
How much does it cost?
The one-time purchase model removes recurring subscription friction, positioning ShotTrackr: GLP-1 & Peptide as a low-cost, high-privacy alternative to subscription-based rivals.
Velocity
Intense developmentShow more...
5 versions in history. Development pace: intense.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads excited. Users appreciate the intuitive tracking interface for health metrics makes daily logging feel efficient for older users and direct developer responsiveness to feature requests builds strong trust and satisfaction among the user base.
How are ratings & reviews evolving?
What users say, by theme
- The intuitive tracking interface for health metrics makes daily logging feel efficient for older users
- Direct developer responsiveness to feature requests builds strong trust and satisfaction among the user base
- Ownership of personal data and the absence of subscription-based monetization models provide a refreshing user experience
- Critical bugs during the initial setup process prevent new users from adding inventory or vials
8 of 8 recent reviews analyzed · limited sample · Excited overall
Read the full review analysisUnlock 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for ShotTrackr: GLP-1 & Peptide
How's the Medical market?
ShotTrackr: GLP-1 & Peptide maintains a 4.36 rating across 14 reviews, positioning it as a high-satisfaction alternative to lower-rated, free-to-use competitors. The $3.99 price point serves as a barrier to entry compared to free rivals, but the privacy-first model sustains its niche appeal.
The rivals identified
By ZipoApps
Both applications provide dosage calculation tools for peptide users, creating direct competition for the same user base.
- ShotTrackr requires a one-time purchase, while Peptide Calculator App is free.
- ShotTrackr mandates no account creation, whereas Peptide Calculator App saves calculation history automatically.
- ShotTrackr focuses on inventory management, while Peptide Calculator App offers specific syringe size selection from U20 to U100.
Semaglutide App for GLP-1Contender
Glippy: GLP-1 Shot TrackerContender
Peptide Tracker & CalculatorContender
PepTracker: Dose LogContender
Peptide Calculator PROContender
InjectlyContender
Peptide Tracker - PeptideKitContender
Regimen: Peptide TrackerContender
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for ShotTrackr: GLP-1 & Peptide
Where is it heading?
The peptide tracking category is consolidating around tools that offer either deep clinical utility or extreme ease of use. ShotTrackr: GLP-1 & Peptide is well-positioned to defend its niche by maintaining its privacy-first stance, provided it resolves the setup friction that currently limits its growth.
- Developer responsiveness to feature requests builds trust, which sustains the app's high rating relative to the category average.
- Critical setup bugs during the initial user journey create a high churn risk for new purchasers.
The SWOT
- One-time purchase model avoids recurring subscription friction
- Offline-first architecture ensures complete data privacy
- Expand compound database to include TRT protocols to capture broader hormone therapy market
Next best moves
Patch inventory setup bugs because 1★ reviews flag initial setup as a primary trust barrier → increase conversion rate
+ 1 more prioritized moveThe counter-intuitive read
Users report: The lack of cloud synchronization is a feature, not a bug…
Read the full takeFeature gaps
Cloud-based cross-device synchronization (available in Peptide Tracker Calculator but absent here) +1
Since the last report: ShotTrackr: GLP-1 & Peptide has expanded its market scope to include TRT protocols and formalized its one-time purchase pricing, while simultaneously surfacing critical setup bugs that hinder new user retention.
Bottom line
ShotTrackr: GLP-1 & Peptide succeeds by prioritizing privacy and removing subscription friction, which resonates with its core user base. Addressing the setup bugs is the primary lever to unlock higher conversion and retention.
Unlock 2 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated